Clinical Trial Update: Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers [NA]

View source ↗

Summary

A clinical trial is evaluating a 12-month multimodal lifestyle management program and its effect on disease-relevant biomarkers in individuals with Monoclonal G…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Uncertain Significance
• Smoldering Multiple Myeloma

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Monoclonal Gammopathy of Uncertain Significance, Smoldering Myeloma | NA | Status: NOT_YET_RECRUITING